GEOPOLITICS | FDA Approves AstraZeneca Breast Cancer Pill

AstraZeneca Plc’s breast cancer pill won approval from the US Food and Drug Administration, according to Bloomberg. The decision is a win for AstraZeneca after the agency’s advisory panel previously voted against the medicine.